Valuation CStone Pharmaceuticals OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 12:24:51 2026-06-12 EDT			5-day change	1st Jan Change
0.5945 ^USD	-14.46%		-.--%	-33.43%

06-25	CStone Pharma Taps Arrotex to Commercialize Sugemalimab in Australia, New Zealand	MT
06-25	CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex Pharmaceuticals for Sugemalimab Across Australia and New Zealand	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	7,845	4,882	2,628	2,759	6,980	7,496	-	-
Change	-	-37.77%	-46.18%	4.99%	153.01%	7.4%	-	-
Enterprise Value (EV) ¹	7,249	4,551	1,950	2,404	6,404	6,968	3,893	3,320
Change	-	-37.22%	-57.15%	23.28%	166.37%	8.81%	-44.13%	-14.73%
P/E	-	-5.32x	-7.11x	-30.9x	-15.3x	-352x	7x	42.6x
PBR	6.63x	10.9x	5.7x	-	10.7x	-	-	-
PEG	-	-	0.1x	0.4x	-0x	3.7x	-0x	-0.5x
Capitalization / Revenue	32.2x	10.1x	5.67x	6.78x	25.9x	15.6x	4.38x	6.8x
EV / Revenue	29.7x	9.45x	4.2x	5.9x	23.8x	14.5x	2.27x	3.01x
EV / EBITDA	-3.99x	-5.1x	-3.33x	-25.9x	-16.5x	-17x	1.98x	4.58x
EV / EBIT	-3.96x	-4.99x	-3.22x	-22.7x	-14.8x	-18.2x	3.48x	18.7x
EV / FCF	-4.57x	-7.43x	-	-	-19.5x	3,484x	52.6x	47.4x
FCF Yield	-21.9%	-13.5%	-	-	-5.12%	0.03%	1.9%	2.11%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-	-0.77	-0.29	-0.07	-0.31	-0.0133	0.67	0.11
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	243.7	481.4	463.8	407.2	269.6	479.3	1,713	1,103
EBITDA ¹	-1,818	-892.9	-585.4	-92.72	-388.6	-409.6	1,962	724.4
EBIT ¹	-1,829	-912.1	-605.6	-106.1	-432.6	-383.2	1,118	177.6
Net income ¹	-1,920	-902.7	-367.2	-91.21	-437	-243.2	687.4	93.49
Net Debt ¹	-596.2	-331.1	-677.7	-354.7	-576.3	-528.2	-3,603	-4,177
Reference price ²	6.737	4.096	2.061	2.161	4.736	4.691	4.691	4.691
Nbr of stocks (in thousands)	1,164,452	1,192,099	1,275,317	1,276,503	1,473,942	1,598,209	-	-
Announcement Date	6/8/22	4/26/23	4/23/24	3/27/25	3/26/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	16.94x	3.69x	9.97x	0.6%	66.56B
UCB	28.53x	5.87x	17.23x	0.55%	57.64B
SAMSUNG BIOLOGICS CO.,LTD.	34.88x	11.82x	22.38x	-.--%	42.24B
CSL LIMITED	-43.93x	3.11x	9.2x	3.49%	39.09B
BIOGEN INC.	34.9x	3.71x	11.39x	-.--%	31.91B
MODERNA, INC.	-9.24x	13.4x	-8.22x	-.--%	31.65B
INCYTE CORPORATION	16.96x	3.25x	9.83x	-.--%	23.35B
INNOVENT BIOLOGICS, INC.	53.7x	5.97x	40.99x	-.--%	18.92B
SWEDISH ORPHAN BIOVITRUM AB	26.89x	5.5x	14.75x	-.--%	17.17B
Average	17.74x	6.26x	14.17x	0.52%	36.5B
Weighted average by Cap.	15.90x	6.18x	13.16x	0.63%